Conseil d'examen du prix des m‚dicaments brevet‚s - Patented Medicine Prices Review Board Canada Wordmark
 
 Français  Contact Us  Help  Search  Canada Site
Home About the
 PMPRB
Order Forms
Feedback
Sitemap
Archives
 Other Sites

Home > Annual Report 2001 Printer Friendly
Annual Report 2001


Annual Report (PDF)

Return to Annual Reports

Table Of Contents

1. Press Release
2. Mission and Values
3. Letter to the Minister
4. Chairperson's Message
5. Highlights for 2001
6. About the Patented Medicine Prices Review Board: Mandate and Jurisdiction
7. Regulating: Prices of Patented Medicines
   7.1. Sales of Drugs in Canada in 2001
   7.2. Compliance and Excessive Price Guidelines
   7.3. Voluntary Compliance Undertaking
   7.4. Quasi-judicial Activities
8. Reporting: Information on Key Pharmaceutical Trends
   8.1. Trends in Drug Prices and Expenditures
   8.2. Reports on Cost Drivers Facing Federal/Provincial/Territorial Drug Plans
   8.3. Analysis of Research-and-Development Expenditures
9. Policy and Research Initiatives
   9.1. Research Agenda
   9.2. Transparency of the Price Review Process
   9.3. Working Group on Price Review Issues
   9.4. Federal/Provincial/Territorial Activities - National Prescription Drug Utilization Information System
   9.5. Environmental Scan and Performance Evaluation
   9.6. Communications
10. Governance
   10.1. Membership and Senior Staff
   10.2. Budget
11. Publications
12. Glossary
13. Annexes
   13.1. Annex 1 - Commencing an Investigation
   13.2. Annex 2 - Patented Drug Products Introduced in 2001
   13.3. Annex 3 - Research and Development
14. Patented Drug Products for Human Use and Canadian Patentees
15. Footnotes

View Full Report
Last Updated: 2003-04-08 Arrow Important Notices